Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Taysha Gene Therapies Inc (NQ: TSHA )

2.110 +0.040 (+1.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 729,873
Open 2.090
Bid (Size) 2.100 (124)
Ask (Size) 2.110 (83)
Prev. Close 2.070
Today's Range 2.050 - 2.150
52wk Range 1.270 - 4.320
Shares Outstanding 64,465,037
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Peeling Back The Layers: Exploring Taysha Gene Therapies Through Analyst Insights
Via Benzinga
TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Misses Revenue for Q2 2024
TSHA stock results show that Taysha Gene Therapies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
+23.39%
+23.39%
1 Month
+4.46%
+4.46%
3 Month
-47.12%
-47.12%
6 Month
-22.14%
-22.14%
1 Year
-41.55%
-41.55%

More News

Read More
Where Taysha Gene Therapies Stands With Analysts
Via Benzinga
Why Is Taysha Gene Therapies (TSHA) Stock Down 14% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
The Analyst Landscape: 16 Takes On Taysha Gene Therapies
Via Benzinga
Breaking Down Taysha Gene Therapies: 16 Analysts Share Their Views
Via Benzinga
11 Analysts Assess Taysha Gene Therapies: What You Need To Know
Via Benzinga
Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
S&P 500 Edges Higher; America's Car-Mart Shares Tumble After Q4 Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Evaluating Taysha Gene Therapies: Insights From 7 Financial Analysts
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Crude Oil Rises 1%; DermTech Shares Plummet
Via Benzinga
Exposures Fossil Fuels
What's Going On With Taysha Gene Therapies Stock Tuesday?
Via Benzinga
TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Spinal Delivery Of Taysha's Gene Therapy Shows Promise In Rare Childhood Neurodegenerative Disease
Via Benzinga
Micron To Rally Around 134%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.